GGrantIndex
← Leaderboards

Michael-Christopher Keogh

Epicypher, Inc.

Google Scholar ↗PubMed ↗ORCID ↗
$24,500,905
Attributed
$33,452,586
Total exposure
22
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $7.6M · FY2017–25
$10M$7.5M$5M$2.5M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$33,452,586 · 22

By mechanism

R44$30,911,750 · 14
R43$2,540,836 · 8

Top collaborators

Most similar at Epicypher, Inc.

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Histones”

Research focus

HistonesChromatinEpigenetic ProcessPost-Translational Protein ProcessingInnovationNucleosomesValidationDrug DevelopmentAntibodiesCellsGenomicsTechnologyMapsSamplingServicesSignal TransductionReagentProtocols DocumentationProteinsRecombinantsChip-SeqBindingResolutionLysine

Grant awards (44)

Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples$1,017,618
R44 · FY2025 · HG · contact PI
Multiomic genomic mapping with long read sequencing$1,270,748
R44 · FY2024 · GM
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping$1,032,776
R44 · FY2024 · HG · contact PI
Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples$1,024,448
R44 · FY2024 · HG · contact PI
Quantitative mapping of dynamic epigenetic states in rare and stimulated immune cells$997,966
R44 · FY2024 · AI · contact PI
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping$184,692
R44 · FY2024 · HG · contact PI
Multiomic genomic mapping with long read sequencing$1,272,936
R44 · FY2023 · GM
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping$1,035,703
R44 · FY2023 · HG · contact PI
A molecular toolbox to accelerate drug development for histone lysine methylation regulators$1,025,085
R44 · FY2023 · TR
Quantification of combinatorial epigenetic modifications using defined nucleosome standards$1,024,490
R44 · FY2023 · GM
Quantitative mapping of dynamic epigenetic states in rare and stimulated immune cells$1,022,964
R44 · FY2023 · AI · contact PI
A new epigenetic toolbox for inflammation research and drug discovery$1,012,272
R44 · FY2023 · AI · contact PI
Scalable and quantitative chromatin profiling from formalin-fixed paraffin-embedded samples$406,324
R43 · FY2023 · HG · contact PI
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping$96,090
R44 · FY2023 · HG · contact PI
A molecular toolbox to accelerate drug development for histone lysine methylation regulators$1,025,085
R44 · FY2022 · TR
Quantitative mapping of combinatorial histone modifications$1,024,752
R44 · FY2022 · HG
Quantification of combinatorial epigenetic modifications using defined nucleosome standards$1,024,490
R44 · FY2022 · GM
Quantitative mapping of dynamic epigenetic states in rare and stimulated immune cells$1,022,665
R44 · FY2022 · AI · contact PI
Development of efficient quantitative chromatin profiling in kit and high-throughput formats$1,020,317
R44 · FY2022 · HG
A new epigenetic toolbox for inflammation research and drug discovery$1,012,272
R44 · FY2022 · AI · contact PI
High-resolution genomic mapping of ssDNA and associated proteins for Alzheimer's disease research$500,000
R43 · FY2022 · AG · contact PI
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping$426,207
R44 · FY2022 · HG · contact PI
Multiomic genomic mapping with long read sequencing$406,352
R44 · FY2022 · GM
Ultrasensitive multiomic platform using epitope-targeted DNA methylation mapping$103,580
R44 · FY2022 · HG · contact PI
Development of efficient quantitative chromatin profiling in kit and high-throughput formats$1,024,792
R44 · FY2021 · HG
Quantitative mapping of combinatorial histone modifications$1,024,752
R44 · FY2021 · HG
A new epigenetic toolbox for inflammation research and drug discovery$1,012,272
R44 · FY2021 · AI · contact PI
Development of novel spike-in controls for quantitative chromatin-associated protein profiling$978,257
R44 · FY2021 · DE
Quantitative and highly versatile chromatin accessibility platform$876,387
R44 · FY2021 · HG · contact PI
Development of novel spike-in controls for quantitative chromatin-associated protein profiling$978,257
R44 · FY2020 · DE
Quantitative and highly versatile chromatin accessibility platform$910,411
R44 · FY2020 · HG · contact PI
Development of efficient quantitative chromatin profiling in kit and high-throughput formats$396,808
R44 · FY2020 · HG
A novel protein engineering tool for rapid manufacturing of designer nucleosomes$984,916
R44 · FY2019 · CA · contact PI
A nucleosome sliding assay platform to screen inhibitors of SWI/SNF chromatin remodeling complexes$853,601
R44 · FY2019 · GM · contact PI
Quantification of combinatorial epigenetic modifications using defined nucleosome standards$299,923
R43 · FY2019 · GM
Quantitative assessment of response to epigenetic-targeted therapy$299,841
R43 · FY2019 · CA · contact PI
Quantitative mapping of combinatorial histone modifications$285,017
R43 · FY2019 · HG
Development of novel spike-in controls for quantitative chromatin-associated protein profiling$259,086
R44 · FY2019 · DE
A novel protein engineering tool for rapid manufacturing of designer nucleosomes$999,997
R44 · FY2018 · CA · contact PI
A nucleosome sliding assay platform to screen inhibitors of SWI/SNF chromatin remodeling complexes$866,168
R44 · FY2018 · GM · contact PI
Aptamer Beacons For High-Throughput Assay Development$300,244
R43 · FY2018 · GM · contact PI
Internally Calibrated Chromatin Immunoprecipitation Using Barcoded Nucleosomes$662,538
R44 · FY2017 · HG · contact PI
Next-Generation Detection Reagents for Chromatin Immunoprecipitation$224,847
R43 · FY2017 · HG · contact PI
A nucleosome sliding assay platform to screen inhibitors of SWI/SNF chromatin remodeling complexes$224,640
R43 · FY2017 · GM · contact PI